Manoj Nerurkar, COO, Syngene, says he expects the company to grow in line with its second quarter results.
With a 30 percent topline growth, Syngene, the research arm of Biocon, reported quarterly earnings for the first time since its listing.
Speaking to CNBC-TV18, Manoj Nerurkar, COO, of the company, says he expects the momentum to continue for the rest of the year.
On currency movements, he says hedging all the long-term contracts protects the company from the rupee-dollar volatility.
The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Dec 2, 2015 02:27 pm